Elections |
2026 Board Elections |
ELECTION OF CANDIDATES |
The ISNCC Nominations and Awards Committee is pleased to present the slate of nominees standing for election in 2026. In 2026, three Board of Director positions are open for election.
General Board Positions (Elected Board members shall serve for a period of four years, beginning July 1, 2026, and will be eligible to be re-elected for one additional term of four years if this is their first term.
3. Member Development Portfolio- The purpose of the Member Development portfolio is to recruit and retain membership of ISNCC in order to maximize engagement with nurses working in cancer care across the world. The primary objective of the Member Development portfolio is to build capacity in cancer nursing and cancer nursing leadership to effect change in local, regional and international communities. This includes the development of new National Cancer Nursing Society’s. As a reminder these positions will commence on July 1st, 2026. |
Nominees By Portfolio |
CORPORATE & PHILANTHROPIC (3)
Gillian Blanchard Oncology Nurse Practitioner, Calvary Mater Newcastle, NSW, Australia Kristin Ferguson Senior Director, Strategic Operations: Bone Marrow Transplant & Cellular Therapy, MedStar Georgetown University Hospital, Washington DC, USA Jo Visser Clinical Territory Manager for pharmaceutical company Takeda Oncology, providing education and support for the Leukemia Franchise.
MEMBER DEVELOPMENT (3)
Yanka Campbell Johns Hopkins Medicine, Baltimore, Maryland, USA Naomi Oyoe Ohene Oti Oncology Nurse Specialist / Head of Nursing, National Radiotherapy Oncology and Nuclear Medicine Centre, Korle Bu Teaching Hospital, Ghana Kristin Ferguson Oversee clinical associates, quality, finance, and administrative staff for bone marrow transplant and cellular therapy program at academic medical center in Washington DC, United States | KNOWLEDGE DEVELOPMENT & DISSEMINATION (5) Dorothy Ngo Sheung Chan Associate Professor, The Nethersole School of Nursing, the Chinese University of Hong Kong, Hong Kong SAR. Anne Mellon Gynaecological Oncology Clinical Nurse Consultant, Hunter New England Local Health District, NSW, Australia. Francisca Mwangangi Lecturer and Researcher, South Eastern Kenya University, Kenya Rajni Sharma Assistant Nursing Superintendent, Homi Bhaha Cancer Hospital, India Chie Watanabe Professor, Showa Medical University, School of Nursing & Rehabilitation Sciences, Department of Nursing, Japan. |
NOMINATIONSISNCC is seeking nominations from individuals interested in opportunities to be involved in ISNCC at the Board level. Individuals with experience working with ISNCC or within national cancer nursing societies with experience relevant to the advertised portfolios are encouraged to nominate. Nominees will need a good command of written and spoken English and access to web based conferencing facilities. Nominators must be a member of a national cancer nursing society in nominee’s country/region or, if no cancer nursing society in that country/region, a member of a national nursing society, or regional / international oncology nursing society (e.g. EONS, AONS, ISNCC), and working in the field of cancer nursing. Self-nominations are eligible. Full details of the criteria for appointment to the vacant positions is available below. Successful candidates will take up their positions for a four year term commencing July 1st, 2026.
The purpose of the Corporate and Philanthropic Development portfolio is to seek opportunities that will bring grants, donations or other revenue sources and potential long-term partnerships to support the work of the International Society of Nurses in Cancer Care.
The
knowledge Development and Dissemination Portfolio is responsible to the
Society for developing ISNCC's position as an international resource
for cancer nurses to advise them on cancer nursing and the nurse's role
in cancer care and ensuring optimal education and practice opportunities
through ISNCC in a culturally sensitive way.
The purpose of the Member Development portfolio is to recruit and retain membership of ISNCC in order to maximize engagement with nurses working in cancer care across the world. The primary objective of the Member Development portfolio is to build capacity in cancer nursing and cancer nursing leadership to effect change in local, regional and international communities. This includes the development of new National Cancer Nursing Society’s. Deadline for nominations is March 6, 2026. As a reminder positions will commence on July 1, 2026. | PLEASE NOTE: you
may start a nomination online at anytime and save a draft in progress.
Please ensure you submit the final nomination before the deadline. Final nominations are at the discretion of the ISNCC Awards and Nominations Committee. Please don’t hesitate to contact ISNCC Head Office with any questions at info@isncc.org. Learn more about ISNCC Board and Committees by clicking the links below |